Glythera Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Glythera Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2811
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Glythera Ltd (Glythera) is a biotechnology company that focuses on the development of antibody drug conjugates (ADCs) and biotherapeutics for the treatment of cancer. The company develops antibody-based therapies for the treatment of cancer and broader based therapeutics. It uses its proprietary linker and stable glycan technologies permalink and premacarb to deliver solutions for development and manufacture efficacious and safe biologics to improve half-life and optimize bio-availability. The company partners with various biotech companies for its technology development activities. Glythera is headquartered in Newcastle upon Tyne, the UK.

Glythera Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Glythera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Glythera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Glythera Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Glythera Raises US$2 Million In Venture Financing 10
Partnerships 11
Avacta Enters into Agreement with Glythera 11
Licensing Agreements 12
Avacta Enters into Licensing Agreement with Glythera 12
Glythera Enters into Licensing Agreement with Cancer Research UK 13
Glythera Enters into Licensing Agreement with IONTAS 14
Glythera Ltd – Key Competitors 15
Glythera Ltd – Key Employees 16
Glythera Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Apr 30, 2018: Glythera Names Professor Kerry Chester to Scientific Advisory Board 18
Jan 17, 2018: Glythera Appoints Chief Scientific Officer and Strengthens SAB 19
Jul 31, 2017: Glythera Appoints Dr Mike Owen as Non-executive Director 20
Jul 31, 2017: Glythera appoints new non-executive director 21
Government and Public Interest 22
Jun 06, 2017: Glythera Launches UK government funded project to develop safer and more efficacious ADCs for the treatment of difficult-to-treat tumours 22
Product News 23
Feb 21, 2017: Glythera: Demonstrates improved activity and safety of PermaLink-based ADCs 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Glythera Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Glythera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Glythera Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Glythera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Glythera Raises US$2 Million In Venture Financing 10
Avacta Enters into Agreement with Glythera 11
Avacta Enters into Licensing Agreement with Glythera 12
Glythera Enters into Licensing Agreement with Cancer Research UK 13
Glythera Enters into Licensing Agreement with IONTAS 14
Glythera Ltd, Key Competitors 15
Glythera Ltd, Key Employees 16

List of Figures
Glythera Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Glythera Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Glythera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Glythera Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Cerebrotech Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cerebrotech Medical Systems Inc (Cerebrotech) is a medical device company focused on the development of neurotechnology solutions for non-invasive monitoring of patients after stroke or traumatic brain injury. The company’s Cerebrotech Visor is a portable non-invasive wireless neuro monitori …
  • Advanced Biological Laboratories SA-医療機器分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Assembly Biosciences Inc (ASMB):製薬・医療:M&Aディール及び事業提携情報
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Bertelsmann SE & Co. KGaA:企業の戦略・SWOT・財務分析
    Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Balfour Beatty plc:企業の戦略・SWOT・財務情報
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nanovis Inc-医療機器分野:企業M&A・提携分析
    Summary Nanovis Inc (Nanovis) is a medical device company that develops and markets tissue regenerating implants for bone and soft tissues. The company provides products such as implant nanosurfaces, implantable scaffolds and cervical plate, among others. Nanovis offers products PEEK interbody syste …
  • Union Jack Oil plc (UJO):企業の財務・戦略的SWOT分析
    Summary Union Jack Oil Plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • Cabot Oil & Gas Corp (COG):企業の財務・戦略的SWOT分析
    Cabot Oil & Gas Corp (COG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • LOT Polish Airlines SA:企業の戦略・SWOT・財務分析
    LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report Summary LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Active Biotech AB (ACTI)-製薬・医療分野:企業M&A・提携分析
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that undertakes the development and commercialization of pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company has five projects in clinical development of which three have been licensed o …
  • GC Pharma (006280):企業の財務・戦略的SWOT分析
    GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • F J Benjamin Holdings Ltd.:企業の戦略・SWOT・財務分析
    F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析
    Summary Mangalam Drugs and Organics Ltd (MDOL) carries out manufacturing and supplying of specialty chemicals, intermediates, and active pharmaceutical ingredients. The company's active pharmaceutical ingredients include amodiaquine HCl, bisoprolol fumarate, artemether, dihydroartemisinin, hydroxy c …
  • Rockwell Automation Inc (ROK):企業の財務・戦略的SWOT分析
    Rockwell Automation Inc (ROK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512):企業の財務・戦略的SWOT分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company prov …
  • Oci Nv
    Oci Nv - Strategy, SWOT and Corporate Finance Report Summary Oci Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • SAS Institute Inc.:企業の戦略・SWOT・財務分析
    SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report Summary SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sodra Skogsagarna ekonomisk forening:企業の戦略的SWOT分析
    Sodra Skogsagarna ekonomisk forening - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆